Morgan Stanley Pulse Biosciences, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 50,425 shares of PLSE stock, worth $861,763. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,425

Previous 61,735 18.32%

Holding current value

$861,763

Previous $1.14 Million 28.86%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$15.61 - $24.56 $176,549 - $277,773	-11,310 Reduced 18.32%	50,425 $811,000
Q4 2024 Feb 14, 2025	SELL	$14.56 - $21.08 $122,828 - $177,830	-8,436 Reduced 12.02%	61,735 $1.14 Million
Q3 2024 May 14, 2025	BUY	$10.83 - $21.83 $326,286 - $657,694	30,128 Added 75.24%	70,171 $1.23 Million
Q3 2024 Nov 14, 2024	BUY	$10.83 - $21.83 $326,286 - $657,694	30,128 Added 75.24%	70,171 $1.23 Million
Q2 2024 May 14, 2025	SELL	$6.69 - $14.54 $145,119 - $315,401	-21,692 Reduced 35.14%	40,043 $448,000
Q2 2024 Oct 17, 2024	BUY	$6.69 - $14.54 $20,464 - $44,477	3,059 Added 8.27%	40,043 $448,000
Q2 2024 Aug 14, 2024	BUY	$6.69 - $14.54 $20,464 - $44,477	3,059 Added 8.27%	40,043 $448,000
Q1 2024 Oct 17, 2024	SELL	$7.8 - $11.02 $23,860 - $33,710	-3,059 Reduced 7.64%	36,984 $322,000
Q1 2024 Aug 16, 2024	SELL	$7.8 - $11.02 $65,941 - $93,163	-8,454 Reduced 18.61%	36,984 $322,000
Q1 2024 May 15, 2024	SELL	$7.8 - $11.02 $65,941 - $93,163	-8,454 Reduced 18.61%	36,984 $322,000
Q4 2023 Aug 16, 2024	BUY	$3.85 - $12.84 $20,770 - $69,271	5,395 Added 13.47%	45,438 $556,000
Q4 2023 Feb 13, 2024	BUY	$3.85 - $12.84 $73,319 - $244,524	19,044 Added 72.15%	45,438 $556,000
Q3 2023 Nov 15, 2023	SELL	$4.03 - $8.73 $18,284 - $39,608	-4,537 Reduced 14.67%	26,394 $106,000
Q2 2023 Aug 14, 2023	BUY	$3.67 - $8.64 $61,600 - $145,022	16,785 Added 118.66%	30,931 $222,000
Q1 2023 May 15, 2023	SELL	$2.48 - $3.88 $13,029 - $20,385	-5,254 Reduced 27.08%	14,146 $47,000
Q4 2022 Feb 14, 2023	BUY	$1.73 - $2.89 $4,089 - $6,831	2,364 Added 13.88%	19,400 $53,000
Q3 2022 Nov 14, 2022	SELL	$1.23 - $2.3 $346,359 - $647,663	-281,593 Reduced 94.3%	17,036 $39,000
Q2 2022 Oct 27, 2022	BUY	$1.48 - $4.28 $51,102 - $147,784	34,529 Added 13.07%	298,629 $457,000
Q2 2022 Aug 15, 2022	BUY	$1.48 - $4.28 $51,102 - $147,784	34,529 Added 13.07%	298,629 $457,000
Q1 2022 Oct 27, 2022	SELL	$4.21 - $14.79 $145,367 - $510,683	-34,529 Reduced 11.56%	264,100 $1.29 Million
Q1 2022 May 13, 2022	BUY	$4.21 - $14.79 $887,388 - $3.12 Million	210,781 Added 395.32%	264,100 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$14.78 - $24.4 $389,393 - $642,842	26,346 Added 97.68%	53,319 $789,000
Q3 2021 Nov 15, 2021	BUY	$17.25 - $26.63 $465,284 - $718,290	26,973 New	26,973 $583,000

Others Institutions Holding PLSE

# of Institutions

Shares Held

5.54M

Call Options Held

76.1K

Put Options Held

60.8K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $634M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account